VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients

Vitamin K antagonists (VKAs) are highly effective but have a narrow therapeutic index and require routine monitoring of the INR. The primary aim of pharmacogenetics (PGx) is to optimize patient care, achieving drug treatments that are personalized according to the genetic profile of each patient. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Misasi, Silvia, Martini, Giuliana, Paoletti, Oriana, Calza, Stefano, Scovoli, Giovanni, Marengoni, Alessandra, Testa, Sophie, Caimi, Luigi, Marchina, Eleonora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207541/
https://www.ncbi.nlm.nih.gov/pubmed/28033245
http://dx.doi.org/10.1097/MD.0000000000005451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207541/
https://www.ncbi.nlm.nih.gov/pubmed/28033245
http://dx.doi.org/10.1097/MD.0000000000005451

Ejemplares similares